Search
01/04/2024
Physical health, primary care utilization and long-term quality of life in borderline personality disorder: A 10-year follow-up study in a Spanish sample
Alvarez-Tomás, I, Soler, J, Schmidt, C, Pascual, JC. Physical health, primary care utilization and long-term quality of life in borderline personality disorder: A 10-year follow-up study in a Spanish sample. JOURNAL OF PSYCHOSOMATIC RESEARCH. 2024; 179DOI:10.1016/j.jpsychores.2024.111623. PMID:38422718. IF:3.300(Q2/3D).
01/04/2024
Practice matters: The role of mindfulness skills in emotion dysregulation in borderline personality disorder
Schmidt, C, Soler, J, Vega, D, Pascual, JC. Practice matters: The role of mindfulness skills in emotion dysregulation in borderline personality disorder. Journal of Contextual Behavioral Science. 2024; 32DOI:10.1016/j.jcbs.2024.100756. PMID:. IF:3.000(Q1/3D).
01/04/2024
Differences in clinical variables of cervical cancer in women with schizophrenia
Casanovas, F, Dinamarca, F, Oller, S, Trabsa, A, Martínez-Sadurní, L, Rodríguez-Seoane, R, Zabaleta, N, Martin, LM, Perez-Sola, V, Ruiz, AI. Differences in clinical variables of cervical cancer in women with schizophrenia. EUROPEAN PSYCHIATRY. 2024; 67DOI:. PMID:. IF:6.700(Q1/1D).
01/04/2024
Esketamine nasal spray shows greater improvement in health-related quality of life over 32 weeks versus quetiapine extended release in patients with treatment resistant depression
Young, AH, Baune, BT, Cardoner, N, Frey, R, Ito, T, Kambarov, Y, Lacerda, A, Rive, B, von Holt, C, Oliveira-Maia, AJ. Esketamine nasal spray shows greater improvement in health-related quality of life over 32 weeks versus quetiapine extended release in patients with treatment resistant depression. EUROPEAN PSYCHIATRY. 2024; 67DOI:10.1192/j.eurpsy.2024.749. PMID:. IF:6.700(Q1/1D).